Ifrah Financial Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,809
Closed -$205K 213
2024
Q2
$205K Sell
1,809
-208
-10% -$26.3K 0.06% 201
2024
Q1
$280K Sell
2,017
-43
-2% -$5.41K 0.08% 176
2023
Q4
$256K Sell
2,060
-177
-8% -$18.1K 0.08% 176
2023
Q3
$209K Sell
2,237
-20
-0.9% -$2.25K 0.07% 191
2023
Q2
$290K Sell
2,257
-50
-2% -$6.05K 0.09% 156
2023
Q1
$268K Sell
2,307
-50
-2% -$5.6K 0.09% 162
2022
Q4
$267K Buy
+2,357
New +$259K 0.09% 164
2022
Q2
Sell
-2,464
Closed -$315K 202
2022
Q1
$315K Buy
2,464
+8
+0.3% +$875 0.09% 162
2021
Q4
$329K Buy
2,456
+20
+0.8% +$2.87K 0.09% 159
2021
Q3
$333K Sell
2,436
-412
-14% -$52K 0.1% 148
2021
Q2
$304K Buy
2,848
+344
+14% +$33K 0.09% 162
2021
Q1
$225K Sell
2,504
-84
-3% -$7.88K 0.07% 196
2020
Q4
$239K Sell
2,588
-76
-3% -$6.79K 0.08% 171
2020
Q3
$274K Buy
+2,664
New +$278K 0.1% 146

Other funds holding DXCM

Ifrah Financial Services's DXCM Position: Q3 2024 in Review

Ifrah Financial Services sold out of DexCom (DXCM) in Q3 2024, closing a stake of 1,809 shares — an estimated $205K sold.

Ifrah Financial Services first reported a position in DXCM in Q3 2020 and held it in 14 quarters. The position peaked at $333K in Q3 2021. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Ifrah Financial Services reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Ifrah Financial Services sold 1,809 DexCom shares in Q3 2024, an estimated $205K.
  • Ifrah Financial Services first reported a position in DexCom in Q3 2020 and held it in 14 quarters.
  • Ifrah Financial Services's DexCom position peaked at $333K in Q3 2021.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Ifrah Financial Services's 13F filing for Q3 2024, filed 31 Oct 2024.